Dr. Janet Rossant, SickKids Research Institute, sits down with CCRM and shares her views on the current trends in regenerative medicine and how the potential for commercialization should factor into research plans. Dr. Rossant touches on her research for Cystic Fibrosis and on the changing culture in academia and the need to consider the clinical applications of research. She then explains how new discoveries can be turned into commercial products with the help of organizations like CCRM and the recently established Ontario Institute for Regenerative Medicine (OIRM).
Dr. Michael West founded Geron Corporation and is CEO of BioTime Inc., which is focused on developing an array of research and therapeutic products using human embryonic stem cell technology. Dr. West is passionate about translating technologies from the test tubes to clinical applications and strongly advocates for pluripotent stem cells’ potential to revolutionize modern health care. He explains why in this video.